Search
for
Sort by
Research 181–210 of 356
- Integrating stem cell biology and organoid technology for skin regenerative therapies
- Formulation Development, Pharmacological Evaluation, and Characterization of <i>Eclipta alba</i> Phytosomes
- Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Bioactive Compound-Loaded Nanocarriers for Hair Growth Promotion: Current Status and Future Perspectives
- The Anti-atopic Lotions Containing Fucoidan Extracted from Ecklonia Cava Impact on Hairless Mice Atopic Dermatitis Skin
- Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging
- Branched Polymer Architecture for Modulating Interactions in Material-Bio Interface
- The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology
- Flavonoids as Potential Wound-Healing Molecules: Emphasis on Pathways Perspective
- Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants
- Flavonoids and saponins: What have we got or missed?
- The potential role of herbal extract Wedelolactone for treating particle-induced osteolysis: an in vivo study
- Comprehensive Insight into Cutaneous Application of Hemp
- Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids
- Hemp (Cannabis sativa L.) Phytochemicals and Their Potential in Agrochemical, Cosmetic, and Food Industries: A Review
- Effects of taxifolin from enzymatic hydrolysis of Rhododendron mucrotulatum on hair growth promotion
- Perilla frutescens: A Rich Source of Pharmacological Active Compounds
- Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Core-shell nanocarriers based on PEGylated hydrophobic hyperbranched polyesters
- Alopecia universalis as a side effect of pegylated interferon α-ribavirin combination therapy for hepatitis C: a rare case report
- Mechanistic study of decreased skin penetration using a combination of sonophoresis with sodium fluorescein-loaded PEGylated liposomes with D-limonene